The SUPPORT Study (Supportive-Expressive Therapy for Cancer Patients) was a landmark randomized trial testing group psychotherapy for women with metastatic breast cancer.
Key finding: No harms were identified. The therapy improved mood, reduced trauma symptoms, and enhanced quality of life without adverse effects.
While individual reactions to any therapy can vary, the study's rigorous design found no evidence of harm—only benefit. It remains a cornerstone of psychosocial oncology.
Always consult a licensed mental health professional for personal concerns.